« Back to Members

Chemo AG, Vienna, Lugano Branch

Chemo AG, Vienna, Lugano Branch

CHEMO believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to safe, quality and affordable medicines, and to continuously expand our efforts and R&D investment to develop new and better therapies.


CHEMO operates across the entire pharmaceutical value chain, delivering specialized expertise in scientific research, development, manufacturing, sales and marketing of a wide range of Active Pharmaceutical Ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal care.

CHEMO established a commercial office in Lugano in 1977 and its core business has been trading group and third party APIs, followed by selling group’s own FDFs. CHEMO Lugano has developed long lasting relationships with laboratories all over the world and specifically in Latin America. Beside its long term business relationship with customers, CHEMO benefits from the group`s own manufacturing network comprising 11 state-of-the-art facilities, 5 chemical and 6 pharmaceutical sites, with cutting-edge technologies, highly qualified professionals, high safety standards, and the most up-to-date equipment to perform a wide variety of chemical reactions and to produce added-value medicines, in a variety of dosage forms.

Via F. Pelli 17
6900 Lugano
T.: +41 91 973 21 01
F.: +41 91 973 21 06
http://www.chemogroup.com
nicola.wicki@chemolugano.com
https://twitter.com/chemogroup
https://www.linkedin.com/company/chemo

  • Main activities
    Licensing-In
    Licensing-Out
    Co-development
    Trading

  • Drug stages
    Registration
    Market
    Generic Plus (505B2)
    Generic

  • Therapeutic areas
    Cancer supportive therapy
    CNS
    Dermatology
    Gastrointestinal
    Gynaecology
    Ophtalmology
    Respiratory

  • Markets
    CH
    EU Top 5
    Rest of Europe
    USA and Canada
    LATAM
    MENA
    BRICS
    ASEAN
    Australia
    Japan

  • Drug product forms
    Inhaler
    Oral (solid)
    Topical

  • Drug substance type
    APIs (1-10kgs/batch)
    APIs (20-200kgs/batch)
    APIs (>200kgs/batch)
    HPAI 10-100g/batch
    HPAI 0.2-5kgs/batch
    HPAI 6-20kgs/batch
    HPAI >20kgs/batch
    Antibiotics
    Steroids

  • Other activities (non pharma)
    Medical Devices
    Natural Products
    Nutraceuticals